AR and prostate carcinoma: IL-1β or TNFα inhibit the growth of androgen receptor (AR)+ LNCaP cells but not that of androgen-independent PC-3 human prostate cancer (PC) cell lines in co-cultivation with monolayers of human diploid fibroblast WI-38 cells derived from embryonic lung tissue [128].